July 2019

Quanta Raises $48 million in Series C Funding Round.

Alcester, Warwickshire, UK.  29 July 2019.  Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announced that it has successfully raised £38 million ($48 million) in a first closing of its Series […]

Quanta Raises $48 million in Series C Funding Round. Read More »

Endotronix 2

Endotronix Enrolls 1st Patient in SIRONA II CE Mark Trial.

Lisle, Illinois.  July 15, 2019.  Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment of the first patient in its prospective, multi-center, SIRONA II trial, in Europe.  The 60-patient study will evaluate safety and efficacy of the Cordella™ Pulmonary Artery Pressure Sensor System (Cordella

Endotronix Enrolls 1st Patient in SIRONA II CE Mark Trial. Read More »

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top